Carroll Jill bought AVLN
May 1, 2026 · Form 4 insider transaction
Carroll Jill bought 277,778 shares of Avalyn Pharma Inc. at $18.00 per share, a transaction worth $5.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The securities are directly held by SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"). SR One Capital Partners II, LP ("SR One Partners II") serves as the general partner of SR One Fund II Aggregator, and SR One Capital Management, LLC serves as the general partner of SR One Partners II. The Reporting Person is a partner of SR One Capital Management, LP, an entity affiliated with SR One Fund II Aggregator, and a limited partner of SR One Partners II. The Reporting Person disclaims beneficial ownership of these securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.